clarithromycin has been researched along with cefaclor anhydrous in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (44.00) | 18.2507 |
| 2000's | 9 (36.00) | 29.6817 |
| 2010's | 5 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ki, CS; Kim, IS; Kim, S; Lee, K; Lee, NY; Oh, WS; Peck, KR; Song, JH | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Bae, S; Kang, Y; Kim, E; Lee, J; Lee, S; Yu, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Dal-Ré, R; García-de-Lomas, J; García-Delafuente, C; Iriarte, V; Martín-Herrero, JE; Mazón, A; Pérez-Trallero, E; Robles, P | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Dubois, J; Fong, IW; Grossman, R; Laforge, J; Small, D; Zakhari, R | 1 |
| Anding, K; Daschner, FD; Engels, I; Lemmen, SW | 1 |
| Andrews, WP; Corder, WT; Gan, VN; Gooch, WM; Khurana, CM | 1 |
| Vetter, N; Waardenburg, FA; Wettengel, R | 1 |
| Carpentier, M; Delmée, M; Glupczynski, Y; Gordts, B; Magerman, K; Simon, A; Surmont, I; Van de Vyvere, M; Van Landuyt, H; Van Nimmen, L; Van Noyen, R | 1 |
| Anastasiou, A; Leotsacos, P; Pavlopoulou, J; Sereti, E; Syriopoulou, V | 1 |
| Bermejo, M; García-de-Lomas, J; García-Ponte, L; Garijo, B; Gimeno, C; Lázaro, MA; Millás, E; Navarro, D | 1 |
| Brookings, E; Gray, B; Swiatlo, E; Waites, K | 1 |
| Felmingham, D; Grüneberg, RN; Harding, I; Robbins, MJ; Shrimpton, S; Tesfaslasie, Y | 1 |
| Hasegawa, Y; Imai, C; Nakae, M; Osaka, K; Sasaki, H; Shibasaki, K; Sugahara, Y; Yasui, H | 1 |
| Hirakata, Y; Igari, J; Kaku, M; Matsuda, J; Misawa, N; Mori, T; Murase, M; Nakamura, A; Nakamura, Y; Oguri, T; Shimada, J; Shimoura, M; Shitara, M; Tachibana, Y; Tazawa, S; Ugajin, K; Umezu, S | 1 |
| Aoshiba, K; Kohri, K; Kondo, M; Nagai, A; Tagaya, E; Tamaoki, J | 1 |
| Goss, TF; Najib, MM; Stein, GE | 1 |
| Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
| Kondo, M; Nagai, A; Tagaya, E; Tamaoki, J | 1 |
| Akashi, S; Arai, I; Hashimoto, Y; Kaneda, Y; Nakaike, S; Takahashi, N | 1 |
| Akhter, N; Anwer, N; Fareed, A; Ghori, RA; Imran, K; Iqbal, ZH; Javaid, A; Khan, MH; Khan, MK; Khan, S; Khan, SU; Mahmood, K; Rahman, F; Siddqui, SJ; Ullah, S | 1 |
1 review(s) available for clarithromycin and cefaclor anhydrous
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 trial(s) available for clarithromycin and cefaclor anhydrous
| Article | Year |
|---|---|
Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
Topics: Bronchitis; Cefaclor; Clarithromycin; Female; Haemophilus influenzae; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Pneumonia; Streptococcus pneumoniae | 1995 |
Clarithromycin and cefaclor suspensions in the treatment of acute otitis media in children.
Topics: Acute Disease; Cefaclor; Child; Child, Preschool; Clarithromycin; Drug Administration Schedule; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Otitis Media; Single-Blind Method; Suspensions; Treatment Outcome | 1993 |
Clarithromycin versus cefaclor for the treatment of mild-to-moderate acute bacterial bronchitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Bronchitis; Cefaclor; Clarithromycin; Double-Blind Method; Female; Humans; Male; Middle Aged | 1993 |
Randomized controlled study of clarithromycin versus cefaclor suspensions in the treatment of acute otitis media in children.
Topics: Acute Disease; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Child; Child, Preschool; Clarithromycin; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Otitis Media; Suspensions | 1995 |
Effect of a short course of clarithromycin therapy on sputum production in patients with chronic airway hypersecretion.
Topics: Adult; Aged; Amoxicillin; Animals; Anti-Bacterial Agents; Bronchiectasis; Bronchitis; Cefaclor; Chlorides; Chronic Disease; Clarithromycin; Double-Blind Method; Erythromycin; Female; Humans; Male; Membrane Potentials; Middle Aged; Rabbits; Sputum; Trachea | 2002 |
Cefaclor AF vs Clarithromycin in acute exacerbation of chronic bronchitis (B3M-PK-AJBG).
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bronchitis, Chronic; Cefaclor; Clarithromycin; Female; Humans; Male; Middle Aged; Single-Blind Method; Treatment Outcome | 2003 |
18 other study(ies) available for clarithromycin and cefaclor anhydrous
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea.
Topics: Ampicillin Resistance; beta-Lactamases; Drug Resistance, Bacterial; Genes, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Korea; Microbial Sensitivity Tests; Mutation; Penicillin-Binding Proteins; Species Specificity | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance.
Topics: Adolescent; Adult; Aged; Amino Acid Sequence; Amino Acid Substitution; Ampicillin; Ampicillin Resistance; beta-Lactamases; Child; Child, Preschool; DNA, Bacterial; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Korea; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Penicillin-Binding Proteins; Population Surveillance; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction; Serotyping; Young Adult | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Spain; Streptococcus pneumoniae; Streptococcus pyogenes; Streptogramin B | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Bactericidal activity of clarithromycin and cefaclor against Streptococcus pneumoniae and Moraxella catarrhalis in healthy volunteers.
Topics: Blood Bactericidal Activity; Cefaclor; Clarithromycin; Humans; Moraxella catarrhalis; Streptococcus pneumoniae | 1994 |
In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefotaxime; Cefuroxime; Child; Child, Preschool; Clarithromycin; Clavulanic Acids; Cross Infection; Haemophilus Infections; Haemophilus influenzae; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Middle Aged | 1996 |
Antimicrobial susceptibility of Streptococcus pneumoniae isolated from pediatric carriers in Spain.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Carrier State; Cefaclor; Cefuroxime; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Infant; Microbial Sensitivity Tests; Penicillins; Spain; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
In vitro activities of oral antimicrobial agents against penicillin-resistant Streptococcus pneumoniae: implications for outpatient treatment.
Topics: Administration, Oral; Adult; Ambulatory Care; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Child; Clarithromycin; Clindamycin; Culture Media; Humans; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cefaclor; Cephalosporins; Ciprofloxacin; Clarithromycin; Common Cold; Community-Acquired Infections; Dose-Response Relationship, Drug; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic; Penicillins; Respiratory System; Respiratory Tract Infections; Streptococcus pneumoniae; United Kingdom | 1998 |
[Drug susceptibility of clinically isolated Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Clarithromycin; Cross Reactions; Drug Resistance, Microbial; Erythromycin; Gastritis; Helicobacter pylori; Humans; Imipenem; Penicillins; Stomach Ulcer; Thienamycins | 1998 |
[Antimicrobial activities of roxithromycin against recently obtained clinical isolates].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cephalosporins; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Erythromycin; Humans; Leucomycins; Methicillin Resistance; Miocamycin; Moraxella catarrhalis; Mycoplasma pneumoniae; Penicillin Resistance; Penicillins; Roxithromycin; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus agalactiae; Streptococcus pneumoniae; Streptococcus pyogenes | 1997 |
Macrolide antibiotics inhibit nitric oxide generation by rat pulmonary alveolar macrophages.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Cefaclor; Clarithromycin; Dose-Response Relationship, Drug; Erythromycin; Gene Expression Regulation, Enzymologic; Humans; Josamycin; Macrophages, Alveolar; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2000 |
Cost-effectiveness of sparfloxacin compared with other oral antimicrobials in outpatient treatment of community-acquired pneumonia.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Azithromycin; Cefaclor; Clarithromycin; Community-Acquired Infections; Cost-Benefit Analysis; Erythromycin; Fluoroquinolones; Humans; Models, Economic; Outpatients; Pneumonia; Treatment Outcome | 2000 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
Clarithromycin inhibits the development of dermatitis in NC/Nga mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cefaclor; Clarithromycin; Dermatitis, Atopic; Dexamethasone; Histocompatibility Antigens Class II; Immunosuppressive Agents; Male; Mast Cells; Mice; Mice, Inbred Strains; Skin; Staphylococcal Skin Infections; Staphylococcus aureus; Time Factors | 2003 |